We are live on ! Find out more

1,541 hedge funds and large institutions have $84.9B invested in Amgen in 2016 Q4 according to their latest regulatory filings, with 167 funds opening new positions, 629 increasing their positions, 566 reducing their positions, and 115 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more first-time investments, than exits

New positions opened: 167 | Existing positions closed: 115

11% more repeat investments, than reductions

Existing positions increased: 629 | Existing positions reduced: 566

2% more funds holding

Funds holding: 1,5181,541 (+23)

1.87% less ownership

Funds ownership: 79.97%78.1% (-1.9%)

14% less capital invested

Capital invested by funds: $99.2B → $84.9B (-$14.2B)

33% less funds holding in top 10

Funds holding in top 10: 9765 (-32)

35% less call options, than puts

Call options by funds: $850M | Put options by funds: $1.32B

Holders
1,541
Holders Change
+23
Holders Change %
+1.52%
% of All Funds
38.45%
Holding in Top 10
65
Holding in Top 10 Change
-32
Holding in Top 10 Change %
-32.99%
% of All Funds
1.62%
New
167
Increased
629
Reduced
566
Closed
115
Calls
$850M
Puts
$1.32B
Net Calls
-$467M
Net Calls Change
-$239M

AMGN Hedge Fund Activity: Q4 2016 in Review

1,541 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q4 2016, worth a combined $84.9B — down 14% from $99.2B a quarter earlier.

Buyers outnumbered sellers: 167 funds opened new AMGN positions and 115 closed out — a net gain of 52 holders — while 629 added to existing stakes and 566 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $624M. The largest seller was Capital Research Global Investors, cutting an estimated $2.02B.

  • 1,541 institutional investors held Amgen (AMGN) as of Q4 2016, up from 1,518 in Q3 2016.
  • Funds reported $84.9B of Amgen stock for Q4 2016, down 14% quarter-over-quarter.
  • 167 funds opened new Amgen positions in Q4 2016 and 115 closed out, a net change of +52 holders.
  • The largest Amgen buyer in Q4 2016 was Fidelity Investments, an estimated $624M added.
  • The largest Amgen seller in Q4 2016 was Capital Research Global Investors, an estimated $2.02B sold.

Based on aggregated 13F filings for Q4 2016.